ARTICLE | Company News
Mount Tam, Tabacalera deal
September 21, 2015 7:00 AM UTC
Mount Tam reverse-merged with TabacaleraYsidron. Mount Tam’s TAM-01 is an mTOR inhibitor to treat systemic lupus erythematosus (SLE). Mount Tam licensed the preclinical compound from the Buck Institut...